Targeted markets Small biotechnology firms and contract research organizations focusing on genomics, single cell analysis, and tissue microdissection present a clear near-term opportunity for NeuroInDx’s KuiqpicK and UnipicK instruments, given their compatibility with most inverted microscopes and rapid single cell collection capabilities.

Cost advantage Position the product as a cost-effective alternative to flow sorting and laser capture systems, highlighting lower capital and operating expenses, simpler workflows, and higher viable cell yields to attract budget-conscious laboratories expanding single cell research programs.

Pilot programs Leverage the low revenue footprint and small team size to propose pilot deployments in target labs to demonstrate speed, versatility, and minimal impact on cell viability, aiming to convert pilots into long-term instrument subscriptions or consumable sales.

Strategic partnership Explore collaborations with academic centers and biotech incubators that require rapid single cell acquisition workflows, offering training, support, and bundled solutions to accelerate adoption among researchers and early adopters.

Product expansion Highlight opportunities to expand the CTAS-based portfolio into new tissue types or cell types, and to develop protocol kits tailored for popular downstream applications such as gene expression profiling and next-generation sequencing, aligning with customers’ end-to-end workflows.